Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells
Matthew B. Dong(Yale University), Sidi Chen(Yale Cancer Center), Roy S. Herbst(The University of Texas MD Anderson Cancer Center), Youssef Errami(Yale Cancer Center), Guangchuan Wang(Shandong University), Paul Renauer(Yale Cancer Center), Xiaoyun Dai(Yale Cancer Center), Lvyun Zhu(Yale Cancer Center), Lupeng Ye(Zhejiang University), Yaying Du(Yale Cancer Center), Ryan D. Chow(Yale University), Krista Y. Chen(Yale Cancer Center), Jonathan J. Park(Yale Cancer Center), Christopher D. Guzman(Yale Cancer Center), Hyunu R. Kim(Yale Cancer Center), Stanley Z. Lam(Yale Cancer Center), Xiaoyu Zhou(Yale Cancer Center), Donald R. Lannin(Yale Cancer Center), J. Zhou(Yale Cancer Center), Johanna Shen(Yale Cancer Center)
Cited by 326
Related Papers
Lung Cancer
|New England Journal of Medicine|2008|2.4k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k
Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1
|Journal of Clinical Oncology|2004|1.7k